Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy

Heart

Volumn 83, Issue 3, 2000, Pages 262-266

  Petkow Dimitrow, P ^a   Krzanowski, M ^a   Nizankowski, R ^a   Szczeklik, A ^a   Dubiel, J S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Coronary blood flow velocity; Hypertrophic cardiomyopathy; Verapamil

Indexed keywords

VERAPAMIL;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; FEMALE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; SYSTOLE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; BLOOD FLOW VELOCITY; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CORONARY CIRCULATION; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART RATE; HUMANS; MALE; REGRESSION ANALYSIS; SYSTOLE; VASODILATOR AGENTS; VERAPAMIL;

EID: 0034120858     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Crowley JJ, Dardas PS, Harcombe AA, et al. Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy. Heart 1997;77:558-63.
2. Asami Y, Yoshida K, Hoxumi T, et al. Assessment of coronary flow reserve in patients with hypertrophic cardiomyopathy using transthoracic color Doppler echocardiography. J Cardiol 1998;32:247-52.
3. Tomochika Y, Tanaka N, Wasaki Y, et al. Assessment of flow profile of left anterior descending coronary artery in hypertrophic cardiomyopathy by transesophagcal pulsed Doppler echocardiography. Am J Cardiol 1993;72:1425-30.
4. Memmola C, Iliceto S, Napoli VF, et al. Coronary flow dynamics and reserve assessed by transesophageal echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol 1994;74:1147-51.
5. Petkow Dimitrow P, Krzanowski M, Bodzon W, et al. Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels 1996;11:160-4.
6. Akasaka T, Yoshikawa J, Yoshida K, et al. Phasic coronary flow characteristics in patients with hypertrophic cardiomyopathy: a study by coronary Doppler catheter. J Am Soc Echocardiogr 1994;7:9-19.
7. Kyriakidis MK, Dernellis JM, Androulakis AE, et al. Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy. Circulation 1997;96:834-41.
8. Higano ST, Yeo TC, Nishimura RA, et al. Coronary hemodynamics in hypertrophic cardiomyopathy: Intracoronary Doppler observations [abstract]. J Am Coll Cardiol 1997;29(suppl):126A.
9. Tsukahara R, Muramatu T, Akimoto N, et al. Evaluation of coronary flow characteristics in patients with hypertrophic cardiomyopathy using a Doppler guidewire [abstract]. J Am Coll Cardiol 1997;29(suppl):462A.
10. Cannon RO, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234 43.
11. Isaaz K, Bruntz JF, Paris D, et al. Abnormal coronary flow velocity pattern in patients with ventricular hypertrophy, angina pectoris, and normal coronary arteries: a transesophageal Doppler echocardiographic study. Am J Heart 1994;128:500-10.
12. Kimball BP, LiPreti V, Bui S, et al. Comparison of proximal left anterior descending and circumflex coronary artery dimensions in aortic valve stenosis and hypertrophic cardiomyopathy. Am J Cardiol 1990;65:767-71.
13. Cuccurullo F, Mezzetti A, Lapenna D, et al. Mechanism of isoproterenol-induced angina pectoris in patients with obstructive hypertrophic cardiomyopathy and normal coronary arteries. Am J Cardiol 1987;60:667-73.
14. Oram H, Fehske W. Relationship between symptoms and coronary blood flow velocity in patients with aortic stenosis [abstract]. Circulation 1994;90(suppl):1-116.
15. O'Keefe JH, Owen RM, Bove AA. Influence of left ventricular mass on coronary cross-sectional area. Am J Cardiol 1987;59;1395-7.
16. Kodama K, Hamada M, Kazatani Y, et al. Clinical characteristics in Japanese patients with coexistent hypertrophic cardiomyopathy and coronary vasospasm. Angiology 1998;49:849-55.
17. Iida H, Fujii T, Miura T, et al. Assessment of endothelium dependent coronary vasodilation in hypertrophic cardiomyopathy [abstract]. Circulation 1996;94:1-502.
18. Jung WI, Sieverding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-42.
19. Udelson JE, Bonow RO, O'Gara PT, et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1989;79:1052-60.
20. Petkow Dimitrow P, Surdacki A, Dubiel JS. Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther 1997;11:741-6.
21. Takase H, Moreau P, Kung Ch, et al. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency; effect of verapamil and trandolapril. Hypertension 1996;27:25-31.
22. Dagenais F, Cartier R, Hollmann C, et al. Calcium-channel blockers preserve endothelial reactivity after ischemia-reperfusion. Ann Thorac Surg 1997;63:1050-6.
23. Dohi Y, Criscione L, Pfeiffer K, et al. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994;24:372-9.
24. Krams R, Kofflard MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998;97;230-3.
25. Caiati C, Montaldo C, Zedda N, et al. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999;99:771-8.
26. Wilson RF, Laughlin DE, Ackell PH, et al. Transluminal subselective measurement of coronary artery flow velocity and vasodilator reserve in man. Circulation 1985;72:82-92.
27. Bartel T, Baumgart S, Muller S, et al. Validation of transthoracic Doppler measurements of coronary flow velocity by intracoronary Doppler guidewire [abstract]. J Am Coll Cardiol 1998;31(suppl C):243C.